Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review

Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) M. J. Seckl et al.   ANNALS OF ONCOLOGY

p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases

(2013) Melina Shoni et al.   GYNECOLOGIC ONCOLOGY

Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009

(2012) A Sita-Lumsden et al.   BRITISH JOURNAL OF CANCER

Current advances in the management of gestational trophoblastic disease

(2012) Ross S. Berkowitz et al.   GYNECOLOGIC ONCOLOGY

Trophoblastic disease

(2012) Hextan Y.S. Ngan et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study

(2011) Roshan Agarwal et al.   LANCET

Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole

(2010) John R. Lurain   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

17Beta-Estradiol Enhances Leptin Expression in Human Placental Cells Through Genomic and Nongenomic Actions1

(2010) Yésica P. Gambino et al.   BIOLOGY OF REPRODUCTION

Gestational trophoblastic disease

(2010) Michael J Seckl et al.   LANCET

Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease

(2009) Mary E. Gaffield et al.   CONTRACEPTION

Molar Pregnancy

(2009) Ross S. Berkowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current management of gestational trophoblastic diseases

(2008) Ross S. Berkowitz et al.   GYNECOLOGIC ONCOLOGY